HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Predicting response to antimicrobial therapy in children with acute sinusitis.

AbstractOBJECTIVE:
To determine prognostic factors that independently predict response to antimicrobial therapy in children with acute sinusitis.
STUDY DESIGN:
A total of 206 children meeting a priori clinical criteria for acute sinusitis who were prescribed antimicrobial therapy by their primary care provider were included. The severity of symptoms in the 8-12 days after treatment was initiated was followed with the use of a validated scale. We examined the univariate and multivariate association between factors present at the time of diagnosis (symptoms, signs, nasopharyngeal culture result, radiograph results) and time to resolution of symptoms. This study was conducted 8-10 years after the 7-valent pneumococcal conjugate vaccination was introduced but before introduction of the 13-valent pneumococcal conjugate vaccination.
RESULTS:
Children with proven nasopharyngeal colonization with Streptococcus pneumoniae improved more rapidly (6.5 vs 8.5 median days to symptom resolution) than those who were not colonized with S pneumoniae. Age and radiograph findings did not predict time to symptom resolution.
CONCLUSIONS:
In children with acute sinusitis, proven nasopharyngeal colonization with S pneumoniae at presentation independently predicted time to symptom resolution. Future randomized, placebo-controlled trials could investigate the usefulness of testing for the presence of nasopharyngeal pathogens as a predictor of response to treatment.
AuthorsNader Shaikh, Ellen R Wald, Jong H Jeong, Marcia Kurs-Lasky, A'delbert Bowen, Lynda L Flom, Alejandro Hoberman
JournalThe Journal of pediatrics (J Pediatr) Vol. 164 Issue 3 Pg. 536-41 (Mar 2014) ISSN: 1097-6833 [Electronic] United States
PMID24367985 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2014 Mosby, Inc. All rights reserved.
Chemical References
  • Anti-Bacterial Agents
  • Amoxicillin-Potassium Clavulanate Combination
  • Amoxicillin
Topics
  • Acute Disease
  • Amoxicillin (therapeutic use)
  • Amoxicillin-Potassium Clavulanate Combination (therapeutic use)
  • Anti-Bacterial Agents (therapeutic use)
  • Child
  • Child, Preschool
  • Female
  • Haemophilus influenzae (isolation & purification)
  • Humans
  • Male
  • Moraxella catarrhalis (isolation & purification)
  • Nasopharynx (microbiology)
  • Prognosis
  • Prospective Studies
  • Sinusitis (drug therapy, microbiology)
  • Streptococcus pneumoniae (isolation & purification)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: